EUR 7.34
(1.1%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 5.92 Million | -75.07 Million | -32.88 Million | 3.56 Million | 2.19 Million |
Net Income | -11.8 Million | -31.66 Million | -240.5 Million | -16.21 Million | -5.77 Million |
Depreciation & Amortization | 19.48 Million | 18.41 Million | 14.2 Million | 11.33 Million | 1.36 Million |
Deferred income taxes | 4.05 Million | -4.98 Million | - | - | - |
Stock-based compensation | 4.94 Million | 24.24 Million | 2.15 Million | 3.47 Million | - |
Change in working capital | -5.47 Million | -63.31 Million | 11.54 Million | 10.28 Million | 7.5 Million |
Other non-cash items | 45.15 Million | 104.51 Million | 213.73 Million | 19.72 Million | -906.18 Thousand |
Investing Cash Flow | -12.99 Million | -13.55 Million | -8.93 Million | -7.67 Million | -2.43 Million |
Investments in PPE | -12.99 Million | -13.55 Million | -8.93 Million | -7.67 Million | -1.1 Million |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 1000.00 | -10.14 Million | -5.63 Million | -4.21 Million | -1.32 Million |
Financing Cash Flow | 13.9 Million | 67.93 Million | 108.96 Million | 6.28 Million | -1.1 Million |
Debt repayment | -15 Million | -8.51 Million | -62.68 Million | -4.01 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | 60 Million | 191.28 Million | 10.41 Million | - |
Other Financing Activities | 1000.00 | -1.15 Million | 171.82 Million | 10.22 Million | -1.1 Million |
Accounts receivables | -14.27 Million | -12.48 Million | -5.46 Million | 204 Thousand | - |
Accounts payables | -505 Thousand | 4.05 Million | 10.47 Million | 11.26 Million | - |
Inventory | 8.25 Million | -52.79 Million | -8.46 Million | -10.36 Million | -7.71 Million |
Other working capital | 1.06 Million | -2.09 Million | 14.99 Million | 9.18 Million | 15.22 Million |
Cash at beginning of period | 54.91 Million | 75.59 Million | 9.07 Million | 6.84 Million | 3.68 Million |
Cash at end of period | 59.28 Million | 54.91 Million | 75.59 Million | 9.07 Million | 807.28 Thousand |
Capital Expenditure | -12.99 Million | -13.55 Million | -8.93 Million | -7.67 Million | -1.1 Million |
Effect of forex changes on cash | -2.45 Million | 21 Thousand | -632 Thousand | 63 Thousand | -55.61 Thousand |
Net cash flow / Change in cash | 4.37 Million | -20.67 Million | 66.51 Million | 2.23 Million | -2.87 Million |
Free Cash Flow | -7.07 Million | -88.62 Million | -41.82 Million | -4.11 Million | 1.08 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -7.83 Million | -7.83 Million | -6.87 Million | -11.8 Million | -6.87 Million | 974.5 Thousand |
Depreciation & Amortization | 5.53 Million | 5.53 Million | 4.91 Million | 19.48 Million | 4.91 Million | 4.82 Million |
Deferred income taxes | - | - | 4.05 Million | 4.05 Million | - | - |
Stock-based compensation | 476 Thousand | 476 Thousand | 1.3 Million | 4.94 Million | 1.3 Million | 1.87 Million |
Change in working capital | -22.19 Million | -22.19 Million | 15.53 Million | -5.47 Million | 15.53 Million | -18.01 Million |
Other non-cash items | 10.92 Million | 10.92 Million | 6.21 Million | 45.15 Million | 6.21 Million | -6.67 Million |
Investing Cash Flow | -2.89 Million | -2.89 Million | -3.98 Million | -12.99 Million | -3.98 Million | -2.46 Million |
Investments in PPE | -876 Thousand | -876 Thousand | -720 Thousand | -12.99 Million | -720 Thousand | -1.29 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -2.02 Million | -2.02 Million | -3.26 Million | 1000.00 | -3.26 Million | -1.17 Million |
Financing Cash Flow | -2.08 Million | -2.08 Million | 6.37 Million | 13.9 Million | 6.37 Million | -575.5 Thousand |
Debt repayment | - | - | -15 Million | -15 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.08 Million | -2.08 Million | 6.37 Million | 1000.00 | 6.37 Million | -575.5 Thousand |
Accounts receivables | 11.22 Million | 11.22 Million | -16.26 Million | -14.27 Million | -16.26 Million | 9.12 Million |
Accounts payables | - | - | -426 Thousand | -505 Thousand | - | -79 Thousand |
Inventory | -24.59 Million | -24.59 Million | 25.64 Million | 8.25 Million | 25.64 Million | -21.52 Million |
Other working capital | -8.82 Million | -8.82 Million | 6.14 Million | 1.06 Million | 6.14 Million | -5.61 Million |
Cash at beginning of period | - | - | 14.6 Million | 54.91 Million | - | 54.91 Million |
Cash at end of period | -17.02 Million | -17.02 Million | 59.28 Million | 59.28 Million | 22.34 Million | 14.6 Million |
Capital Expenditure | -876 Thousand | -876 Thousand | -720 Thousand | -12.99 Million | -720 Thousand | -1.29 Million |
Effect of forex changes on cash | 1.03 Million | 1.03 Million | -1.13 Million | -2.45 Million | -1.13 Million | -95.5 Thousand |
Net cash flow / Change in cash | -17.02 Million | -17.02 Million | 44.68 Million | 4.37 Million | 22.34 Million | -40.31 Million |
Free Cash Flow | -13.96 Million | -13.96 Million | 20.36 Million | -7.07 Million | 20.36 Million | -18.31 Million |
688678
PHCG
KANORICHEM
RFX
AURG
8358